Robertson Stephens Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Sell
4,138
-16
-0.4% -$3.45K 0.03% 310
2026
Q1
$834K Buy
4,154
+36
+0.9% +$7.45K 0.02% 323
2025
Q4
$850K Buy
4,118
+115
+3% +$23K 0.02% 338
2025
Q3
$718K Buy
4,003
+326
+9% +$55.5K 0.02% 294
2025
Q2
$593K Buy
3,677
+576
+19% +$91.8K 0.02% 342
2025
Q1
$528K Sell
3,101
-340
-10% -$59K 0.02% 359
2024
Q4
$572K Buy
3,441
+217
+7% +$37.1K 0.02% 340
2024
Q3
$554K Buy
3,224
+57
+2% +$9.44K 0.02% 389
2024
Q2
$488K Sell
3,167
-1,354
-30% -$203K 0.02% 338
2024
Q1
$695K Sell
4,521
-22
-0.5% -$3.35K 0.04% 288
2023
Q4
$718K Buy
4,543
+51
+1% +$7.33K 0.04% 258
2023
Q3
$657K Sell
4,492
-1,409
-24% -$215K 0.04% 260
2023
Q2
$904K Sell
5,901
-429
-7% -$66.9K 0.06% 203
2023
Q1
$981K Sell
6,330
-245
-4% -$38.5K 0.08% 199
2022
Q4
$1.01M Buy
+6,575
New +$970K 0.1% 174

Other funds holding FBT

Robertson Stephens Wealth Management's FBT Position: Q2 2026 in Review

Robertson Stephens Wealth Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.39% in Q2 2026, selling an estimated $3.45K and leaving 4,138 shares worth $1.03M. The position accounts for 0.03% of the portfolio, ranked #310.

Robertson Stephens Wealth Management first reported a position in FBT in Q4 2022 and has held it in 15 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Robertson Stephens Wealth Management held 4,138 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.03M as of Q2 2026.
  • Robertson Stephens Wealth Management sold 16 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $3.45K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #310 holding.
  • Robertson Stephens Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 15 quarters since.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.